1 / 6

SUPA PALS From molecules to medicine

SUPA PALS From molecules to medicine. Collaboration, Expansion, and Opportunities for Growth Cait MacPhee and Kishan Dholakia. SUPA PALS 2012. 65 academic staff 81 PhD students 2009-2011: £6.3m new funding (EPSRC, BBSRC, Royal Society, ERC) 182 publications . SWOT.

dennis
Download Presentation

SUPA PALS From molecules to medicine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. SUPA PALSFrom molecules to medicine Collaboration, Expansion, and Opportunities for Growth Cait MacPhee and Kishan Dholakia

  2. SUPA PALS 2012 • 65 academic staff • 81 PhD students • 2009-2011: • £6.3m new funding (EPSRC, BBSRC, Royal Society, ERC) • 182 publications

  3. SWOT

  4. Developing & Inspiring the Future • BBSRC DTP “EASTBio” • 34 studentships awarded annually across consortium • (at least) 4 joint studentships awarded to PALS/EASTBio in 2012 (Bioenergy and Industrial Biotech) • Joint training programme • INSPIRE • 14 joint industrial studentships awarded • M2 lasers, Galil Medical, Logitech, Mentholatum, Agilent, Horiba Jobin Yvon • In the next 5 years we will have trained ~150 PhD students

  5. Future strategy 1: Diagnosis & Therapy for (Degenerative) Disease • Current: • MRI, CT, PET, sensors, photonics, mass spectrometry, diagnostics...+... • Applications to 21st century challenges: Parkinson’s, Alzheimer’s, diabetes, cancer, cataract • Future: • Co-ordinated approach to funding (eg critical mass for appropriate grants, identifiable SUPA PALS brand) • How to get there: • cross-disciplinary networking • Showcase event • Joint bids for new grant income, targeting EU funding and industrial collaborations

  6. Future strategy 2: Single Cell Analysis • Current: • Computational systems biology, cell manipulation (opto- and sono-), cell and molecular visualisation, quantitative molecular biology and –omics technology • Future: • Application of technology to stem cells, synthetic biology • How to get there: • cross-disciplinary networking • Joint Bids for new grant income/DTCs/Horizon ‘2020’ - agility to international landscape

More Related